Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Immunotherapy

From cancer evolution to targeting faulty genetics – our new fellows

Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.

News digest – e-cig inquiry, breast cancer risk, junk food promotions, and… a lack of goodwill?

This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

Viruses may boost immunotherapy success

Viruses may improve the success rate of immunotherapy treatments, according to two new studies.

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

Lung cancer discovery points to a better way to personalise immunotherapy

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

8 new challenges between us and beating cancer

We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research.

Discovery could guide immunotherapy for lung cancer

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Pages